KemPharm, Inc. Reports First Quarter 2016 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to KemPharm, Inc. Reports First Quarter 2016 Results

KemPharm (KMPH) Tops Q1 EPS by 26c

May 12, 2016 4:47 PM EDT

KemPharm (NASDAQ: KMPH) reported Q1 EPS of ($0.20), $0.26 better than the analyst estimate of ($0.46).

This has been a significant period for KemPharm. Last weeks joint advisory committee meeting with the FDAs Anesthetic and Analgesic Drug Products and Drug Safety and Risk Management committees voted in support of approving Apadaz for the management of acute pain that requires an opioid, yet recommended against including abuse deterrent... More